Main > ONCOLOGY (**) > Lung>NSCLC>MET>RET Fusion+ > TREAT.: > USA. R. Pralsetinib Capsules

---

USA. R. Pralsetinib Capsules's subsections
(*) USA Approval Date: 2020. 09.04.
Companion Diagnostics>
Company
Company (CoMarketing USA)
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2020. 09.15.
TradeMark
TradeMark Web-Site

USA. R. Pralsetinib Capsules's products
This section has no products